Financhill
Back

Tarsus Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41

TARS
Tarsus Pharmaceuticals, Inc.

Last Price:
$69.99
Seasonality Move:
-4.91%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARS is experiencing slight selling pressure.

Tarsus Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 67.62 Buy
20-day SMA: 68.5 Buy
50-day SMA: 68.31 Buy
200-day SMA: 63.48 Buy
8-day EMA: 68.5 Buy
20-day EMA: 68.56 Buy
50-day EMA: 69.63 Buy
200-day EMA: 64.69 Buy

Tarsus Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 53.73 Buy
Chaikin Money Flow: -21998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66 - 74.06) Buy
Bollinger Bands (100): (66.92 - 79.62) Sell

Tarsus Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Tarsus Pharmaceuticals, Inc. Stock

Is Tarsus Pharmaceuticals, Inc. Stock a Buy?

TARS Technical Analysis vs Fundamental Analysis

Sell
41
Tarsus Pharmaceuticals, Inc. (TARS) is a Sell

Is Tarsus Pharmaceuticals, Inc. a Buy or a Sell?

Tarsus Pharmaceuticals, Inc. Stock Info

Market Cap:
3B
Price in USD:
70.12
Share Volume:
370.8K

Tarsus Pharmaceuticals, Inc. 52-Week Range

52-Week High:
85.25
52-Week Low:
38.51
Sell
41
Tarsus Pharmaceuticals, Inc. (TARS) is a Sell

Tarsus Pharmaceuticals, Inc. Share Price Forecast

Is Tarsus Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Tarsus Pharmaceuticals, Inc.

Is Tarsus Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.38 per share, an increase this year of $0.69 per share, and an increase next year of $3.60 per share.

Technical Analysis of Tarsus Pharmaceuticals, Inc.

Should I short Tarsus Pharmaceuticals, Inc. stock?

* Tarsus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.